New regulations for drug prices will implement the industry integration in July
Release time: 2012-02-21 & nbsp & nbsp & nbsp Source:
Recently，Interim Measures for the "Interim Measures for Price Management of Drug Control links" (hereinafter referred to as "Measures") The last round of comments。Press the determined timetable，New rules will be officially implemented on July 1，Nearly 20,000 companies are affected。
16th，Reporters contact Kyushu Tong, the largest private pharmaceutical circulation enterprise in China、Hubei Provincial Medical Reform Office and other units learned，This opinion draft is only circulated in a small range。The impact on it，There are different opinions in the industry。
but，Most opinion believes，"Measures" once implemented，It will break the existing pharmaceutical purchase and sale mode，Touch the lifeline of some medical circulation companies，High drug prices are also expected to be pulled down to a certain extent。
Interpretation
Drug price increase will have a clear upper limit
The biggest feature of "Measures"，It is intended to be wholesale link of drugs (that is, medical insurance drugs) within the scope of government pricing、The difference rate (amount) of the sales link of medical institutions (amount)，Implement the upper limit control。Where，The highest price increase of the drugs for wholesale links must not exceed 194 yuan，The maximum difference in the drug sales link of the medical institution shall not exceed 69 yuan。
Current，Pharmaceutical agency sales model widely stake sports betting appstake sports betting appexisted in the domestic pharmaceutical industry，It began to develop rapidly with the rapid release of the pharmaceutical market in 2000，Gradually becoming the mainstream sales model of the pharmaceutical market。
Where，Supply of the current reserve price，Display channels and terminals from agents，The agent to solve the low -cost agent model of income and related expenses through a commercial ticket or paying taxes to the manufacturer is used by many small and medium -sized companies.。
"This mode circulation chain is long，，Great cost，If the medicine does not have enough profit space，It is almost difficult to maintain the normal operation of this model。"Wuhan Medical Industry Association told reporters，"High pricing of drugs is a prerequisite for the existence of the agency sales model，and disorderly commercial circulation and extensive price management are soils where the agency sales model survives。”
"Unlike a single drug increase rate for the current drug price management，"Measures" divides this key data into two categories: circulation links and medical institutions，Different difference rate bonuses are implemented in each，In fact, the highest pricing of each link of the drug circulation。"Yang Maozhi, Chairman of Wuhan Yang Kuchu Pharmaceutical Co., Ltd. analyzes。
New Deal has the "three control" pavement in Guangdong
Yesterday，Liu Baolin, chairman of Kyushu Tong, the largest private pharmaceutical business enterprise in China，In a telephone interview with reporters，The first sentence is "Nothing much change。"Previous，Kyushu Tong has received a draft of "Measures" issued by the National Development and Reform Commission。Current，Kyushu Tong has not yet made feedback。
According to an introduction，As a policy pilot province of the National Development and Reform Commission，Guangdong has issued and implemented the "Notice on" Three Controls "Management of Drug Price" in 2010。
Industry insiders，This pilot was later recognized by the National Development and Reform Commission。The "Measures" that will be promoted in July this time in July，It is the practice experience of Guangdong's "three controls"，The purpose is to want to alleviate the problems between the price difference between the factory price and the retail price。
but，Reporter's discussion draft display，On the basis of "three controls" in Guangdong，"Measures" further refine the control of the price increase rate，The actual difference (amount) of the actual difference rate (amount) required to wholesale links in the drug who requires the wholesale link of the drug is based on the "low price and height rate，high price difference rate "method，Implement the deviation rate (amount) control。
Perform according to this requirements，The highest price increase of the drugs for wholesale links must not exceed 194 yuan，The maximum difference in the drug sales link of the medical institution shall not exceed 69 yuan，is the biggest difference between "Measures" and Guangdong's "three controls"。
Pharmaceutical circulation industry integration
Different from Kyushu Tong received the "Measures" for the "Measures".，Many other local medicine -related units，If you don't know the new policy。
Yesterday afternoon，Reporter called Hubei Provincial Medical Industry Association、Hubei Provincial Medical Reform Office and Wuhan Yang Gee Pharmaceutical Company，All units said that they did not receive the "Measures"。
If it is implemented on schedule，The impact on the Measures，Xu Yang, deputy director of the Hubei Provincial Medical Reform Office，According to management，The National Development and Reform Commission officially launched a similar policy，Our province will introduce specific supporting rules，Corresponding specifications of drug circulation。
Liu Baolin thinks，Can it be observed as scheduled。But if it is implemented，Impact one positive and negative，The front is expected to lower the drug price to a certain extent。
Negative influence，"Belica Mode" has the most negative impact -it must increase the factory price and increase taxes、At the same time, the sales cost for the hospital cannot be operated from the corporate tax，Therefore, it may bring a substantial impact on the sales of such drugs。
At the same time，"Pack" commercial enterprise，It will disappear with the "base price mode"，So as to form a positive push for the integration of the drug circulation industry，That is, some drug purchase and marketing model will produce new changes。In the form of medicine，Small packaging medicines may replace a large number of large packaging drugs。
Impact
The My stake betting appstake sports betting appcost of seeing a doctor is reduced?
Industry insiders said，If the opinion can be officially introduced，The cost of consumers who purchase medicines will be greatly reduced。
According to an introduction，In the past, the old policy was in suppressing the price of virtual high drugs，Mainly a high price limit on the final retail link，and the design and wholesale design is not much，New comments include the factory and wholesale of the medicine into the scope of the monitoring。
Introduction to the person in charge of a chain pharmacy，The control of the highest retail price should have little effect on drug sales，Current，The profit of the retail of the drug is more reasonable，After the new policy is implemented，Some high -priced drug retail prices will be sharply reduced，For some ordinary medicines，The space for its decline is not large。
The pharmaceutical industry will be completely shuffled
Now，Because the competent price of my country's price implements the highest retail price management of drug prices，So the company can not break through the highest retail price，Autonomous determination of transaction price，So a large number of enterprises sell drugs in a "base price package sales" method，All the expenses of the intermediate links are passed on to the circulation link。The retail price is different from the factory price on the market。
"Companies living for tax tickets will completely turn off。"Introduction of a person in charge of a pharmaceutical factory in Wuhan，The same medicine，In the past, we might be transferred from manufacturers to hospitals and pharmacies.，Many of them are just opening a VAT invoice，Lift the price of drugs to earn profit，And in the future, a drug may only pass a powerful intermediary from the manufacturer，Enter the hospital directly。
Pharmacy and medical institutions as retail terminals，They also have some concerns about the New Deal。
"Some small circulation companies will gradually lose the market，Will the powerful intermediate chamber of commerce form a monopoly? "Introduction to the person in charge of a chain pharmacy，The profit of the pharmacy and wholesalers is very thin，They have a big profit point，It also comes from the "low price and high difference rate" medicine pushed by some small middlemen，stake betting appIf such small middlemen stake betting appdo not repeat the large middlemen who have the right to speak, there is a large middleman who has the right to speak，It is likely to obtain the right to speak for drugs。
separate pricing will improve the quality of drug purchase
Future，When the medical institution is pricing for drugs，For different medicines，Different bonus policies also implement。
Past，Regardless of the price of drugs，When the medical institution is pricing for drugs，You can uniformly increase the price 15%。Opinions stipulate，In the future, the absolute addition of drugs under the unit price of less than 30 yuan will increase，Drugs above 30 yuan are reduced。
Introduction to industry insiders，This move can reduce the preferences of high -priced drugs for medical institutions，Improve the quality of drugs for sale。"Solving this problem thoroughly，Then you need to break the 'Medicine of Medicine'。"Sales staff in Guangzhou Chen Liji Pharmaceutical Co., Ltd. introduced，Under the premise of the same cure，prescribing "high -priced medicine、Big prescription "hospital can get a higher difference，separate pricing drugs can only ensure that consumers can buy better quality medicines，and the price may also increase。(Zhang Ying Shi Peng)
16th，Reporters contact Kyushu Tong, the largest private pharmaceutical circulation enterprise in China、Hubei Provincial Medical Reform Office and other units learned，This opinion draft is only circulated in a small range。The impact on it，There are different opinions in the industry。
but，Most opinion believes，"Measures" once implemented，It will break the existing pharmaceutical purchase and sale mode，Touch the lifeline of some medical circulation companies，High drug prices are also expected to be pulled down to a certain extent。
Interpretation
Drug price increase will have a clear upper limit
The biggest feature of "Measures"，It is intended to be wholesale link of drugs (that is, medical insurance drugs) within the scope of government pricing、The difference rate (amount) of the sales link of medical institutions (amount)，Implement the upper limit control。Where，The highest price increase of the drugs for wholesale links must not exceed 194 yuan，The maximum difference in the drug sales link of the medical institution shall not exceed 69 yuan。
Current，Pharmaceutical agency sales model widely stake sports betting appstake sports betting appexisted in the domestic pharmaceutical industry，It began to develop rapidly with the rapid release of the pharmaceutical market in 2000，Gradually becoming the mainstream sales model of the pharmaceutical market。
Where，Supply of the current reserve price，Display channels and terminals from agents，The agent to solve the low -cost agent model of income and related expenses through a commercial ticket or paying taxes to the manufacturer is used by many small and medium -sized companies.。
"This mode circulation chain is long，，Great cost，If the medicine does not have enough profit space，It is almost difficult to maintain the normal operation of this model。"Wuhan Medical Industry Association told reporters，"High pricing of drugs is a prerequisite for the existence of the agency sales model，and disorderly commercial circulation and extensive price management are soils where the agency sales model survives。”
"Unlike a single drug increase rate for the current drug price management，"Measures" divides this key data into two categories: circulation links and medical institutions，Different difference rate bonuses are implemented in each，In fact, the highest pricing of each link of the drug circulation。"Yang Maozhi, Chairman of Wuhan Yang Kuchu Pharmaceutical Co., Ltd. analyzes。
New Deal has the "three control" pavement in Guangdong
Yesterday，Liu Baolin, chairman of Kyushu Tong, the largest private pharmaceutical business enterprise in China，In a telephone interview with reporters，The first sentence is "Nothing much change。"Previous，Kyushu Tong has received a draft of "Measures" issued by the National Development and Reform Commission。Current，Kyushu Tong has not yet made feedback。
According to an introduction，As a policy pilot province of the National Development and Reform Commission，Guangdong has issued and implemented the "Notice on" Three Controls "Management of Drug Price" in 2010。
Industry insiders，This pilot was later recognized by the National Development and Reform Commission。The "Measures" that will be promoted in July this time in July，It is the practice experience of Guangdong's "three controls"，The purpose is to want to alleviate the problems between the price difference between the factory price and the retail price。
but，Reporter's discussion draft display，On the basis of "three controls" in Guangdong，"Measures" further refine the control of the price increase rate，The actual difference (amount) of the actual difference rate (amount) required to wholesale links in the drug who requires the wholesale link of the drug is based on the "low price and height rate，high price difference rate "method，Implement the deviation rate (amount) control。
Perform according to this requirements，The highest price increase of the drugs for wholesale links must not exceed 194 yuan，The maximum difference in the drug sales link of the medical institution shall not exceed 69 yuan，is the biggest difference between "Measures" and Guangdong's "three controls"。
Pharmaceutical circulation industry integration
Different from Kyushu Tong received the "Measures" for the "Measures".，Many other local medicine -related units，If you don't know the new policy。
Yesterday afternoon，Reporter called Hubei Provincial Medical Industry Association、Hubei Provincial Medical Reform Office and Wuhan Yang Gee Pharmaceutical Company，All units said that they did not receive the "Measures"。
If it is implemented on schedule，The impact on the Measures，Xu Yang, deputy director of the Hubei Provincial Medical Reform Office，According to management，The National Development and Reform Commission officially launched a similar policy，Our province will introduce specific supporting rules，Corresponding specifications of drug circulation。
Liu Baolin thinks，Can it be observed as scheduled。But if it is implemented，Impact one positive and negative，The front is expected to lower the drug price to a certain extent。
Negative influence，"Belica Mode" has the most negative impact -it must increase the factory price and increase taxes、At the same time, the sales cost for the hospital cannot be operated from the corporate tax，Therefore, it may bring a substantial impact on the sales of such drugs。
At the same time，"Pack" commercial enterprise，It will disappear with the "base price mode"，So as to form a positive push for the integration of the drug circulation industry，That is, some drug purchase and marketing model will produce new changes。In the form of medicine，Small packaging medicines may replace a large number of large packaging drugs。
Impact
The My stake betting appstake sports betting appcost of seeing a doctor is reduced?
Industry insiders said，If the opinion can be officially introduced，The cost of consumers who purchase medicines will be greatly reduced。
According to an introduction，In the past, the old policy was in suppressing the price of virtual high drugs，Mainly a high price limit on the final retail link，and the design and wholesale design is not much，New comments include the factory and wholesale of the medicine into the scope of the monitoring。
Introduction to the person in charge of a chain pharmacy，The control of the highest retail price should have little effect on drug sales，Current，The profit of the retail of the drug is more reasonable，After the new policy is implemented，Some high -priced drug retail prices will be sharply reduced，For some ordinary medicines，The space for its decline is not large。
The pharmaceutical industry will be completely shuffled
Now，Because the competent price of my country's price implements the highest retail price management of drug prices，So the company can not break through the highest retail price，Autonomous determination of transaction price，So a large number of enterprises sell drugs in a "base price package sales" method，All the expenses of the intermediate links are passed on to the circulation link。The retail price is different from the factory price on the market。
"Companies living for tax tickets will completely turn off。"Introduction of a person in charge of a pharmaceutical factory in Wuhan，The same medicine，In the past, we might be transferred from manufacturers to hospitals and pharmacies.，Many of them are just opening a VAT invoice，Lift the price of drugs to earn profit，And in the future, a drug may only pass a powerful intermediary from the manufacturer，Enter the hospital directly。
Pharmacy and medical institutions as retail terminals，They also have some concerns about the New Deal。
"Some small circulation companies will gradually lose the market，Will the powerful intermediate chamber of commerce form a monopoly? "Introduction to the person in charge of a chain pharmacy，The profit of the pharmacy and wholesalers is very thin，They have a big profit point，It also comes from the "low price and high difference rate" medicine pushed by some small middlemen，stake betting appIf such small middlemen stake betting appdo not repeat the large middlemen who have the right to speak, there is a large middleman who has the right to speak，It is likely to obtain the right to speak for drugs。
separate pricing will improve the quality of drug purchase
Future，When the medical institution is pricing for drugs，For different medicines，Different bonus policies also implement。
Past，Regardless of the price of drugs，When the medical institution is pricing for drugs，You can uniformly increase the price 15%。Opinions stipulate，In the future, the absolute addition of drugs under the unit price of less than 30 yuan will increase，Drugs above 30 yuan are reduced。
Introduction to industry insiders，This move can reduce the preferences of high -priced drugs for medical institutions，Improve the quality of drugs for sale。"Solving this problem thoroughly，Then you need to break the 'Medicine of Medicine'。"Sales staff in Guangzhou Chen Liji Pharmaceutical Co., Ltd. introduced，Under the premise of the same cure，prescribing "high -priced medicine、Big prescription "hospital can get a higher difference，separate pricing drugs can only ensure that consumers can buy better quality medicines，and the price may also increase。(Zhang Ying Shi Peng)
